Should I buy Visteon (VC) stock or is it too late?

Visteon · Consumer Discretionary · price $87

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 61% of its targets hit on this sector (220 calls tested). It aims for $107 (+24 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).

The 3 reliable analysts $127+47 %

The 8 other firms $131+51 %

How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $127 median. “The 8 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Visteon

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Deutsche Bank	71 %	+39.8 %	7	$132 +53%
UBS	75 %	+21.1 %	12	$107 +24%
Barclays	81 %	+17.9 %	16	$125 +44%
RBC Capital	62 %	+4.5 %	13	$127 +47%
Wells Fargo	64 %	+4.2 %	28	$134 +55%
JP Morgan	56 %	+4.1 %	9	$145 +68%
Goldman Sachs	50 %	-15.8 %	8	$104 +20%
Baird	25 %	-15.9 %	8	$121 +40%

In short — Should you invest in Visteon? Is it too late, still worth it? Analysts are fairly positive (73% buy, median target $129, i.e. +49%), and the most reliable on VC targets even higher. But the stock is volatile. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

73% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.
Median price target $129, i.e. +49% from the current price ($87).
The most reliable firm on VC, Barclays (81% hit rate, 16 scored calls), targets $125 (call made on October 9, 2026, maturing on October 9, 2027) (+44%) in its most recent call, and $110 (call made on January 23, 2026, maturing on January 23, 2027) (+27%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 11 ratings, 3 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.

The analyst consensus on VC

Median target $129 (+49%) · 11 ratings · Buy consensus

Strong Buy00%

Buy873%

Hold327%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Visteon now?

We won't decide for you. The facts: 73% of analysts rate it a buy, median target $129 (+49%), and Barclays (most reliable on VC, 81%) targets $125. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Visteon?

Not according to analysts: the median target ($129) is still +49% above the current price ($87) (most reliable on VC: Barclays, 81%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Visteon still worth investing in?

It depends on the gap between the price ($87) and its estimated value: analysts target $129 on median (+49%), with 73% buys (most reliable on VC: Barclays, 81%). Cross-check with their real reliability on VC and the cautions above. Information, not advice.

What's the main risk in buying VC?

The consensus is not unanimous: of 11 ratings, 3 are neutral.

→ Go deeper: the full Visteon profile (consensus, analyst reliability, price target, performance).